Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors

Andy S. Ding(Johns Hopkins Medicine), Michael Lim(Stanford Medicine)

Frontiers in Immunology

July 23, 2019

10.3389/fimmu.2019.01715

Cited by 52

Related Papers

Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model

|PLoS ONE|2014|236

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment

|Clinical and Developmental Immunology|2011|147

A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials

|Cancers|2019|104

CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future

|Frontiers in Immunology|2022|97

PD-L1 expression in medulloblastoma: an evaluation by subgroup

|Oncotarget|2018|62